Inventor · disambiguated record
Li Gan
Also filed as: GAN LI · GAN LI-MING
16 granted patents·6 pending applications·48 citations·filing 2001–2023
91Inventor score
Files withAGY THERAPEUTICS INC3ASTRAZENECA AB3DAVID GLADSTONE INST3GAN LI3THE J DAVID GLADSTONE INST2
Top patents by PatentIndex Score
22 records- 0185US11000525B21-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidaseASTRAZENECA AB·Filed 2018·Granted May 11, 2021·2 cites·2 claims
- 0284US10016430B21-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidaseASTRAZENECA AB·Filed 2017·Granted Jul 10, 2018·5 cites·4 claims
- 0384US6924109B2High-throughput transcriptome and functional validation analysisAGY THERAPEUTICS INC·Filed 2002·Granted Aug 2, 2005·12 cites·21 claims
- 0483US8420613B2Methods and compositions for reducing amyloid beta levelsGAN LI·Filed 2007·Granted Apr 16, 2013·6 cites·12 claims
- 0581US9585907B2Methods and compositions for modulating Tau levelsTHE J DAVID GLADSTONE INST·Filed 2015·Granted Mar 7, 2017·3 cites·20 claims
- 0681US8691519B2Methods and compositions for reducing amyloid beta levelsDAVID GLADSTONE INST·Filed 2013·Granted Apr 8, 2014·4 cites·9 claims
- 0779US9347085B2Methods and compositions for reducing amyloid beta levelsDAVID GLADSTONE INST·Filed 2014·Granted May 24, 2016·3 cites·21 claims
- 0879US7951367B2Methods and compositions for reducing amyloid beta levelsDAVID GLADSTONE INST·Filed 2007·Granted May 31, 2011·5 cites·11 claims
- 0976US9040521B2Methods and compositions for modulating tau levelsGAN LI·Filed 2010·Granted May 26, 2015·3 cites·18 claims
- 1075US8388953B2Method of increasing cathepsin B-induced cleavage of amyloid-β peptidesGAN LI·Filed 2010·Granted Mar 5, 2013·4 cites·11 claims
- 1172US11975004B21-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidaseASTRAZENECA AB·Filed 2021·Granted May 7, 2024·0 cites·4 claims
- 1264US6841351B2High-throughput transcriptome and functional validation analysisAGY THERAPEUTICS INC·Filed 2001·Granted Jan 11, 2005·1 cites·25 claims
- 1357US10877053B2Method of determining an analyte concentrationROCHE DIAGNOSTICS OPERATIONS INC·Filed 2018·Granted Dec 29, 2020·0 cites·16 claims
- 1457US2005123962A1Regulated nucleic acids in pathogenesis of alzheimer's diseaseAGY THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 1556US2005176030A1Regulated nucleic acids in pathogenesis of Alzheimer's DiseaseFiled 2004·Application pending·0 cites
- 1653US10004753B2Methods for treating tauopathyTHE J DAVID GLADSTONE INST·Filed 2016·Granted Jun 26, 2018·0 cites·20 claims
- 1753US2025163052A1cGAS INHIBITORS AND USES THEREOFUNIV CORNELL·Filed 2023·Application pending·0 cites
- 1852US2005053936A1High-throughput transcriptome and functional validation analysisFiled 2002·Application pending·0 cites
- 1950US2022192980A1Cationic hyaluronic acid coated spanlastics and preparation and application thereofFBC SHANGHAI PHARMACEUTICAL TECH CO LTD·Filed 2020·Application pending·0 cites
- 2044US11866475B2Modified RNA encoding VEGF-A polypeptides, formulations, and uses relating theretoMODERNATX INC·Filed 2017·Granted Jan 9, 2024·0 cites·26 claims
- 2132US8920835B2Paliperidone double-layered osmotic pump controlled release tablet and preparation method thereofGAN YONG·Filed 2010·Granted Dec 30, 2014·0 cites·22 claims
- 2230US2006263298A1AssayGAN LI-MING·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Li Gan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →